Scott Plotkin

16.8k citations
206 papers · 10.0k · 1 hit paper · h-index 50

Impact in

  • Neurology top 0.1%
    • Neurofibromatosis and Schwannoma Cases
    • Vascular Malformations Diagnosis and Treatment
    • Neuroblastoma Research and Treatments
  • Genetics top 0.2%
    • Glioma Diagnosis and Treatment

Papers in

  • Neurology 131
    • Neurofibromatosis and Schwannoma Cases 120
    • Vascular Malformations Diagnosis and Treatment 12
    • Neuroblastoma Research and Treatments 10
    • CNS Lymphoma Diagnosis and Treatment 9
  • Genetics 34
    • Glioma Diagnosis and Treatment 34
Co-authors
Tracy T. Batchelor (23 shared papers)Vanessa L. Merker (41 shared papers)Anat O Stemmer-Rachamimov (27 shared papers)Patrick Yung Wen (12 shared papers)Abba J. Kastin (6 shared papers)Emmanuelle di Tomaso (7 shared papers)Alma Gregory Sorensen (5 shared papers)William A. Banks (5 shared papers)
Journals
Neurology (25 papers)Journal of Neuro-Oncology (15 papers)Neuro-Oncology (9 papers)Journal of Clinical Oncology (7 papers)Otology & Neurotology (5 papers)
Partner nations
United StatesUnited KingdomGermany

In The Last Decade

Scott Plotkin

194 papers receiving 9.6k citations

Scott Plotkin's Hit Papers

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients 2007 · 1.5k citations
1.5k0+6+12Years since publication4008001.2k
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2007 Cancer Cell

Peers

Scott Plotkin
Comparison fields: 5 of 136
  • Neurology 4.1k
  • Genetics 2.0k
  • Cancer Research 929
  • Epidemiology 2.1k
  • Biological Psychiatry 117
Replace Jérôme Honnorat with:
Jérôme Honnorat France
Ian E. McCutcheon United States
Wolfgang Grisold Austria
William T. Couldwell United States
Andrew T. Parsa United States
Elisabeth Jane Rushing United States
Juha E. Jääskeläinen Finland
Peter A.E. Sillevis Smitt Netherlands
Ulrich Sure Germany
L. Regli Switzerland
Scott Plotkin relative to Jérôme Honnorat France Jérôme Honnorat's profile →
Citations per field
00.5×1.5×1.9×
Jérôme Honnorat · 1×
Citations per year

Countries citing papers authored by Scott Plotkin

Since Specialization
Citations

This map shows the geographic impact of Scott Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Plotkin more than expected).

Fields of papers citing papers by Scott Plotkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Plotkin. The network helps show where Scott Plotkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott Plotkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Plotkin Line = papers co-authored together Scott Plotkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.

#Work
1
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Cancer Cell ·Tracy T. Batchelor, Alma Gregory Sorensen, Emmanuelle di Tomaso, Wei-Ting Zhang, D. G. Duda, Kenneth Stuart Cohen, Kevin Robert Kozak, Daniel P. Cahill, Poe-Jou Chen, Mingwang Zhu, Marek Ancukiewicz, Maciej M. Mrugala, Scott Plotkin, Jan Drappatz, David N. Louis, Percy S. Ivy, David T. Scadden, Thomas Benner, Jay S. Loeffler, Patrick Yung Wen, (unknown)
Hit paper breakdown →		20071480
2
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Journal of Clinical Oncology ·Tracy T. Batchelor, D. G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott Plotkin, Elizabeth Robins Gerstner, April F. Eichler, Jan Drappatz, Fred H. Hochberg, Thomas Benner, David N. Louis, Kenneth Stuart Cohen, Houng Chea, Alexis Exarhopoulos, Jay S. Loeffler, Marsha A. Moses, Percy S. Ivy, Alma Gregory Sorensen, Patrick Yung Wen, (unknown)
2010434
3
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism.
Journal of Pharmacology and Experimental Therapeutics ·William A. Banks, Luis A. Ortiz, Scott Plotkin, Abba J. Kastin
1991415
4
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
Journal of Clinical Oncology ·David A. Reardon, Karen E. Fink, Tom Mikkelsen, Timothy F. Cloughesy, A. O’Neill, Scott Plotkin, Michael Glantz, Paula D. Ravin, Jeffrey J. Raizer, Keith M. Rich, David Schiff, William R. Shapiro, Susan Burdette-Radoux, Edward J. Dropcho, Sabine M. Wittemer, Johannes Nippgen, Martin A. Picard, L. Burt Nabors
2008407
5
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
New England Journal of Medicine ·Scott Plotkin, Anat O Stemmer-Rachamimov, Fred G. Barker, Chris F. Halpin, Timothy P. Padera, A. W. R. TYRRELL, Alma Gregory Sorensen, (unknown), Emmanuelle di Tomaso
2009380
6
Diagnostic criteria for schwannomatosis
Neurology ·Mia MacCollin, E. Antonio Chiocca, D. Gareth Evans, Jan M. Friedman, R. Horvitz, Diego Jaramillo, Michael H. Lev, Victor Felix Mautner, Michihito Niimura, Scott Plotkin, Christine Nai-Mei Sang, Anat O Stemmer-Rachamimov, E. Steve Roach
2005300
7
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
Molecular and Cellular Biology ·Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott Plotkin, Brendan D. Manning, Anat O Stemmer-Rachamimov, James F. Gusella, Vijaya Ramesh
2009232
8
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Neuro-Oncology ·Thomas Joseph Kaley, Patrick Yung Wen, David Schiff, Keith Lloyd Ligon, Sam Haidar, Sasan Karimi, Andrew B. Lassman, Craig P. Nolan, Lisa Marie DeAngelis, Igor T. Gavrilovic, Andrew David Norden, Jan Drappatz, Eudocia Q. Lee, Benjamin W. Purow, Scott Plotkin, Tracy T. Batchelor, Lauren E. Abrey, Antonio M. P. Omuro
2014213
9
Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial
Journal of Clinical Oncology ·Areej R El-Jawahri, Lisa Podgurski, April F. Eichler, Scott Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes
2009199
10
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2
Otology & Neurotology ·Scott Plotkin, Vanessa L. Merker, Chris F. Halpin, Dominique L. Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker
2012193
11
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Neuro-Oncology ·Christine Lu‐Emerson, Matija Snuderl, Nathaniel D. Kirkpatrick, Jermaine Goveia, Christian J. Davidson, Yuhui Huang, Lars Riedemann, Justin M. Taylor, Percy S. Ivy, D. G. Duda, Marek Ancukiewicz, Scott Plotkin, A. S., Elizabeth Robins Gerstner, April F. Eichler, Jörg Dietrich, Anat O Stemmer-Rachamimov, Tracy T. Batchelor, R. K. Jain
2013183
12
Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate
Clinical Cancer Research ·Scott Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn Jay Lesser, L. Burt Nabors, Brian H. Chon, Tracy T. Batchelor
2004172
13
Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape
Cancer Research ·Emmanuelle di Tomaso, Matija Snuderl, Walid S. Kamoun, D. G. Duda, Pavan K. Auluck, Ladan Fazlollahi, Ovidiu C. Andronesi, Matthew P. Frosch, Patrick Yung Wen, Scott Plotkin, E. Tessa Hedley‐Whyte, Alma Gregory Sorensen, Tracy T. Batchelor, (unknown)
2011165
14
Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients
The Oncologist ·Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat O Stemmer-Rachamimov, Scott Plotkin
2012162
15
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
American Journal of Medical Genetics Part A ·Scott Plotkin, Jaishri O'Neill Blakeley, D. Gareth Evans, Clemens Oliver Hanemann, Theo J.M. Hulsebos, Kim Hunter‐Schaedle, Ganjam V. Kalpana, Bruce R. Korf, Ludwine M. Messiaen, Laura Papi, Nancy Ratner, Larry S. Sherman, Miriam J. Smith, Anat O Stemmer-Rachamimov, Jérémie Vitte, Marco Giovannini
2013134
16
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis
Clinical Genetics ·C. D. Boyd, Miriam J. Smith, Lan Kluwe, A. Balogh, Mia MacCollin, Scott Plotkin
2008126
17
Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis
PLoS ONE ·Scott Plotkin, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Sonia Esparza, Vanessa L. Merker, Lance L. Munn, Alona Muzikansky, Manor Askenazi, Rosa Nguyen, Ralph Wenzel, Victor Felix Mautner
2012122
18
Recommendations for imaging tumor response in neurofibromatosis clinical trials
Neurology ·Eva Dombi, Simone L. Ardern‐Holmes, Dusica Babovic‐Vuksanovic, Fred G. Barker, Steve E. J. Connor, D. Gareth Evans, Michael J. Fisher, Stéphane Goutagny, Gordon J. Harris, Diego Jaramillo, Matthias A. Karajannis, Bruce R. Korf, Victor Mautner, Scott Plotkin, Tina Young Poussaint, Kent A. Robertson, Chie‐Schin Shih, B. Widemann
2013113
19
Value of PET in the Assessment of Patients with Neurofibromatosis Type 1
American Journal of Roentgenology ·Miriam A. Bredella, Martin Torriani, Francis John Hornicek, Hugue A. Ouellette, William E. Plamer, Ziv M. Williams, Allan J. Fischman, Scott Plotkin
2007109
20
Genetic Causes of Brain Tumors: Neurofibromatosis, Tuberous Sclerosis, von Hippel-Lindau, and Other Syndromes
Neurologic Clinics ·Christopher James Farrell, Scott Plotkin
2007109

About Scott Plotkin

Scott Plotkin is a scholar working on Neurology, Genetics, Epidemiology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 206 papers that have together received 10.0k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (120 papers), Meningioma and schwannoma management (43 papers), Glioma Diagnosis and Treatment (34 papers), Sarcoma Diagnosis and Treatment (16 papers), Vascular Malformations Diagnosis and Treatment (12 papers), Chromatin Remodeling and Cancer (11 papers), Neuroblastoma Research and Treatments (10 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Neurology (4.1k citations), Genetics (2.0k citations), Cancer Research (929 citations), Epidemiology (2.1k citations) and Biological Psychiatry (117 citations). Scott Plotkin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Tracy T. Batchelor, Vanessa L. Merker, Anat O Stemmer-Rachamimov, Patrick Yung Wen, Abba J. Kastin, Emmanuelle di Tomaso, Alma Gregory Sorensen, William A. Banks, D. G. Duda and Fred G. Barker. Their work appears in journals such as Neurology, Journal of Neuro-Oncology, Neuro-Oncology, Journal of Clinical Oncology and Otology & Neurotology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérôme HonnoratBreakdown of academic impact, for papers by Ian E. McCutcheonBreakdown of academic impact, for papers by Wolfgang GrisoldBreakdown of academic impact, for papers by William T. CouldwellBreakdown of academic impact, for papers by Andrew T. ParsaBreakdown of academic impact, for papers by Elisabeth Jane RushingBreakdown of academic impact, for papers by Juha E. JääskeläinenBreakdown of academic impact, for papers by Peter A.E. Sillevis SmittBreakdown of academic impact, for papers by Ulrich SureBreakdown of academic impact, for papers by L. Regli